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Lee and Daniel Meeting ProceedingsThe 2008 Annual Scientific Meeting of the International So-
ciety for Minimally Invasive Cardiothoracic Surgery was
held in Boston from June 11 to June 14. Over the course
of the meeting, participants and attendees learned about
the latest advances and the state of the art in minimally inva-
sive techniques and technologies for cardiothoracic surgery.
This review provides a brief overview of some of the inno-
vative topics that garnered significant discussion during the
scientific sessions.
CARDIAC SURGERY
Surgical Treatment of Atrial Fibrillation
Atrial fibrillation remains a significant problem in the car-
diothoracic patient population and a truly effective, defini-
tive treatment remains elusive. Innovative developments
presented at the meeting focused on minimally invasive ac-
cess approaches, such as minithoracotomy, robotic, totally
endoscopic, and closed chest techniques, to perform atrial
ablation surgery. Traditional approaches for procedures
such as the Cox-Maze have required a full median sternot-
omy and cardiopulmonary bypass. New techniques have
allowed the Cox-Maze procedure to be performed success-
fully in 16 patients via a right minithoracotomy and femoral
vessel cannulation,1 as well as a totally pericardioscopic
ex-Maze procedure completed in 22 patients without cardio-
pulmonary bypass and excellent short-term results.2 Other
topics of discussion included the extent of lesion sets and
the optimal choice of an energy source. The consensus
seemed to be that lone pulmonary vein isolation is insuffi-
cient for successful control of atrial fibrillation, and that
the use of biatrial lesion sets or the Cox-Maze procedure is
generally the most successful. Bipolar radiofrequency abla-
tion in combination with cryothermia seemed to provide the
most consistent results, although there was some debate
about the need for exclusion of the left atrial appendage.
Percutaneous Valvular Therapies
There has been tremendous attention and excitement in re-
cent years within the cardiovascular community surrounding
percutaneous valve therapies, with initial studies and devices
focused on the aortic valve. The first clinical experience in
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ment via the femoral route in 27 patients was presented.3
All patients were high risk for conventional surgery with se-
vere symptomatic aortic stenosis, and the third-generation
CoreValve aortic revalving system (CoreValve Inc, Irvine,
Calif.) was deployed. The mean aortic valve gradient de-
creased from 44 mm Hg to 8 mm Hg, whereas the aortic
valve area increased from 0.75 cm2 to 1.5 cm2 with 4%mor-
tality at 30 days. This was accompanied by a significant im-
provement in NewYork Heart Association status in the early
postprocedure period, suggesting that percutaneous aortic
valve replacement is a safe and effective treatment for severe
aortic stenosis in high-risk and elderly patients.
Transapical aortic valve implantation is another approach
for percutaneous aortic valve therapy. Ninety-four high-risk,
elderly patients were treated with the Edwards SAPIEN de-
vice (Edwards Lifesciences, Irvine, Calif) in a hybrid oper-
ation under fluoroscopic and echocardiographic guidance.
The majority of cases were completed without bypass, and
the 30-day and 1-year survivals were 90% and 71%, respec-
tively. Additional larger-scale studies are needed to fully as-
sess the clinical impact of these percutaneous devices, but
early data show that they may be of benefit in the high-
risk patient population.
Coronary Revascularization
Sutureless anastomotic devices for coronary revasculari-
zation is a burgeoning field of interest and the topic of signif-
icant amounts of research. These devices may be particularly
relevant and useful in allowing minimally invasive ap-
proaches for coronary surgery, such as totally endoscopic
beating heart procedures.
The first report of the Food and Drug Administration trial
assessing the efficacy of the Pas-Port (Cardica, Inc., Red-
wood City, Calif) sutureless anastomosis device for coro-
nary revascularization was presented. More than 200
patients were included in the multicenter prospective study,
and initial results showed that the Pas-Port device was not
inferior to hand-sewn anastomoses. The device had graft pa-
tency similar to the hand-sewn technique but did offer a mar-
ginal time savings of just more than 5 minutes per surgery.
There was no increase in adverse events associated with
use of the Pas-Port device. The safety of the Heartstring de-
vice (MAQUET, Rastatt, Germany) in the construction of
clampless proximal coronary anastomoses was assessed in
434 patients undergoing isolated coronary artery bypass
grafting. The results showed that the anastomoses can be
successfully created with minimal stroke risk even in
patients with severe ascending aortic atherosclerosis.4ardiovascular Surgery c Volume 136, Number 4 1107
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VATS ¼ video-assisted thoracic surgery
Minimally Invasive Valve Approaches and
Techniques
Minimally invasive mitral valve surgery is quickly be-
coming the standard of care in many institutions. The ap-
proach used most commonly is a right minithoracotomy,
often via port access. Such techniques may be particularly
useful in reoperative cases, in which median sternotomy
can be technically challenging because of limited exposure
and previous bypass grafts.
A dual-center review of 890 video-assisted minimally
invasive mitral valve surgeries, including repair or replace-
ment, showed that such procedures alone or in combination
with other cardiac procedures are safe and reproducible.5
Thirty-day mortality for all cases was 3%, with the most
common complication being reexploration for bleeding.
Myocardial protectionwas achieved via antegrade cardiople-
gia and transthoracic clamping, cold fibrillatory arrest, or
endoaortic balloon occlusion. The latter was associated
with a statistically insignificant higher incidence of aortic
dissection.
Minimally invasive reoperative mitral valve surgery in
151 patients via right lateral minithoracotomy and femoral
cannulation for cardiopulmonary bypass revealed 3-year
survivals of 80% and 73% for valve repair and replace-
ment, respectively.6 Early mortality was 5%, which was
significantly lower than the predicted EuroSCORE mortal-
ity risk of 17%, demonstrating that minimally invasive mi-
tral valve reoperation via this approach is safe and effective
with good medium-term results. A second study of 651
cases of port-access reoperative mitral valve surgery via
a right minithoracotomy showed similar excellent results,
with only 1 conversion to sternotomy for acute aortic dis-
section.7
THORACIC SURGERY
Minimally Invasive Thoracic Surgery
The thoracic sessions provided a forum for discussion of
the continued evolution of thoracoscopic, robotic, and hy-
brid procedures for the entire gamut of thoracic surgery.
The conference format encouraged active participation of
the attendees in a practical arrangement that allowed for di-
rect interaction and instruction from an assembly of the lead-
ing international experts in minimally invasive surgery. The
thoracic postgraduate course reviewed new techniques in
mediastinal staging- video-assisted thoracic surgery
(VATS) procedures, including sleeve resection and sympa-
thectomy; endoluminal therapies; radiofrequency ablation;
and setup for robotic procedures.1108 The Journal of Thoracic and Cardiovascular SuMediastinum and Staging
Controversy exists regarding the completeness of resec-
tion for VATS approaches to thymectomy and the use of
less-invasive techniques when thymoma is involved. A re-
view of 72 patients who underwent VATS thymectomy
with a right-sided approach demonstrated complete stable
remission rates that were comparable (41.2% for nonthy-
moma vs 38% for thymoma) and similar to previous reports
via open techniques.8
Surgical staging of the mediastinum in non–small cell
lung cancer has always played an important role in determin-
ing operative candidates. Traditional cervical mediastino-
scopy has been limited by higher false-negative rates
because of nodal sampling and inability to assess lymph
nodes in additional stations, such as levels 5 and 6 (for
evaluation of left upper lobe tumors). The combination of
endoscopic techniques and extended transcervical ap-
proaches is allowing surgeons to overcome these limitations.
There is an initial learning curve to the use of transcervical
mediastinotomy for anteroposterior window evaluation. A
review of 100 patients who underwent the technique found
that careful review of preoperative computed tomography
scan data allows those selecting initial patients for the proce-
dure to increase their probability of successful lymph node
dissection.9 The product of the thoracic inlet distance and
anterior mediastinum was calculated and used to formulate
a cervical mediastinotomy index that accurately predicted
difficult patient populations for this technique.
The largest reported series of transcervical extended me-
diastinal lymphadenectomy for preoperative staging of
non–small cell lung cancer was presented.10 Operative tech-
nique involves a collar incision followed by sternal elevation
using a specially developed retractor for full visualization of
bilateral recurrent laryngeal nerves and dissection of all
mediastinal lymph nodes, with the exception of station 9.
A total of 421 patients were included in the review, and
the mean number of dissected nodes in each patient was
38 (range 15–85). N2 nodes were found in 26% of patients.
There was a 2.6% rate of temporary nerve palsy, and a 0.5%
rate of permanent nerve palsy. Patients who had negative re-
sults from transcervical extended mediastinal lymphadenec-
tomy were followed after thoracotomy: Omitted N2 nodes
were observed in 4%, and omitted normal mediastinal nodes
were observed in 6.8%. This technique of bilateral medias-
tinal lymphadenectomy yields impressive lymph node
dissection rates with a sensitivity of 94.7% for N2 to N3
node discovery.
Thoracoscopic Advances
Lung cancer with chest wall invasion has traditionally
been recognized as a contraindication to minimally invasive
approaches. The first case of en bloc right upper lobectomy
with rib resection3-5 was performed with 2 ports and a 4-cmrgery c October 2008
Lee and Daniel Meeting Proceedingsutility incision.11 A video of the procedure was presented,
and the use of an endoscopic bone cutter was demonstrated,
showing that this technique is feasible and may warrant fur-
ther study for applicability in these patients.
Robotic Surgery
Several general thoracic procedures have been performed
via a totally robotic or robotic-assisted technique. Although
laparoscopic or open surgery remains the standard of care,
robotic techniques provide several advantages, and addi-
tional long-term data may ultimately prove such approaches
to be superior in select cases.
Seventy-eight patients underwent a robotic laparoscopic
modified Belsey fundoplasty for gastroesophageal reflux
disease, a procedure that has traditionally been performed
via an open left thoracotomy.12 The robotic approach was
thought to afford better visualization of the gastroesophageal
junction than traditional laparoscopic methods, and when
combined with the Belsey wrap it resulted in no evidence
of gas bloat syndrome with a mean follow-up of 28 months.
The recurrence rate was 5%, and these patients did subse-
quently require open repair.
Thirty-three patients underwent robotic-assisted right
chest esophageal mobilization and lymph node dissection
with esophagogastrostomy for esophageal cancer.13 The
mean operative time was 9 hours with a conversion rate to
thoracotomy of 24% and 1 anastomotic leak (3%), with no
evidence of local recurrence at short-term follow-up. The
study demonstrated the feasibility of robotic-assisted esoph-
agectomy, although further refinement of the procedure is
required to address the relatively high conversion rate.
A prospective study including 129 patients undergoing
robotic-assisted thymectomy via a 3-port left-sided tech-
nique demonstrated excellent results that may encourage
further centers to adopt this procedure.14 The mean operative
time was 184 minutes with a 2.3% conversion rate. The rate
of complete stable remission of myasthenia gravis was
greater than 40% with an average follow-up of 16 months.
The safety and benefits of traditional VATS approaches to
pulmonary lobectomy have been well documented.15 In an
effort to improve on VATS techniques with better visualiza-
tion and instrument maneuverability, the robotic system was
used in 62 lobectomies with the introduction of a fourthThe Journal of Thoracic and Carm.16 Setup time averaged 25 minutes with an operative
time of 172 minutes. Approximately half of the patients
(45%) were discharged within 2 days, reinforcing the bene-
fits of less-invasive surgery for anatomic resections.
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